Keywords: fda, approves, non-cfc, asthma, inhalers, using, zephex
FDA approves non-CFC asthma inhalers using Zephex 134a
Article | 25 May 2001
The US Food and Drug Administration has approved GlaxoSmithKline'sVentolin HFA (albuterol sulfate), a new version in a metered-dose inhaler, using ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
